Hypothesis

Hormetic interventions extend lifespan only when administered during a specific circadian window in which the core clock protein BMAL1 acetylates NRF2 (and indirectly HSF1/FOXO), boosting their transcriptional activity. Outside this window, the same stressors fail to activate cytoprotective pathways and instead engage HIF‑1α‑mediated NF‑κB signaling, producing a net inflammatory response that negates any benefit.

Mechanistic Basis

BMAL1 exhibits histone acetyltransferase activity toward lysine residues on NRF2, increasing its nuclear retention and affinity for antioxidant response elements (ARE). This acetylation peaks in the early subjective day (circadian time ZT4‑ZT8 in mice) when NAD+ levels are moderate and SIRT1 activity is low, permitting acetylation to persist. Simultaneously, BMAL1 represses REV‑ERBα, reducing competition for NRF2 binding. When a hormetic stressor such as sulforaphane, mild heat shock, or intermittent fasting occurs during this window, acetylated NRF2 drives robust transcription of glutathione‑synthesizing enzymes and HSP70, enhancing damage clearance.

If the stressor is delivered outside the BMAL1‑acetylation window (e.g., ZT16‑ZT20), NRF2 remains largely cytoplasmic due to low acetylation and heightened KEAP1‑mediated degradation. The cellular redox shift instead stabilizes HIF‑1α, which recruits p300/CBP to NF‑κB promoters, amplifying pro‑inflammatory cytokines (IL‑6, TNF‑α). The resulting inflammaging outweighs any transient antioxidant response, explaining the modest and inconsistent lifespan gains reported across hormesis studies.

Testable Predictions

1. Timing of sulforaphane administration – Male C57BL/6J mice receiving 5 µmol/g sulforaphane by oral gavage at ZT6 will show a median lifespan increase of ~20 % compared with vehicle; the same dose at ZT18 will produce no significant change or a slight decrease.
2. NRF2 acetylation rhythm – Liver lysates harvested every 4 h over 24 h will reveal a sinusoidal pattern of NRF2‑K623 acetylation, peaking at ZT6 and troughing at ZT18, matching published ChIP‑seq for BMAL1 at the Nrf2 promoter (see [3] ).
3. BMAL1 dependence – Liver‑specific Bmal1 knockout mice will lose the time‑dependent benefit of sulforaphane; both ZT6 and ZT18 groups will exhibit similar NRF2 target gene expression and lifespan.
4. Inflammatory shift – Mistimed (ZT18) sulforaphane treatment will elevate serum IL‑6 and TNF‑α levels 2‑fold relative to ZT6‑treated controls, an effect blocked by the HIF‑1α inhibitor PX‑478.
5. NAD+ modulation – Boosting NAD+ with NR (nicotinamide riboside) during the mistimed window will increase SIRT1 activity, deacetylate HIF‑1α, and partially rescue the inflammatory response, restoring a modest lifespan extension.

Potential Pitfalls and Controls

• Stressor intensity must stay within the hormetic range; overt toxicity will confound timing effects.
• Peripheral clocks can become desynchronized under constant darkness; experiments should be conducted under 12 h/12 h light‑dark cycles with zeitgeber time verified via PER2::LUC bioluminescence.
• Compensatory upregulation of alternative stress pathways (e.g., ATF6) may mask NRF2 effects; measuring multiple arms of the integrated stress response will be necessary.

By directly linking the circadian acetylation state of NRF2 to hormetic efficacy, this hypothesis shifts the focus from "stress dose" to "stress timing" and offers a clear, falsifiable roadmap for designing chronotherapeutic interventions that truly extend healthspan.